Transcranial Temporal Interference Stimulation Targeted of the Amygdala as an Intervention for Alcohol Use Disorder Patients
Starting soon · Not applicable · Has a placebo group
Conditions studied: Alcohol Use Disorder
In brief
The purpose of this research is to investigate the efficacy of transcranial temporal interference stimulation (tTIS) targeting the amygdala in patients with alcohol use disorder.
Key facts
- Study ID
- NCT07472673
- Run by
- Shanghai Mental Health Center
- People needed
- 60
- Starts
- 2026-02-15
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-03-16
Who can join
Age: 18 and older, up to 60. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- aged 18 to 60 years old;
- Meets the DSM-5 diagnostic criteria for alcohol use disorder;
- Normal or corrected normal vision and hearing;
- Able to cooperate in completing the questionnaire assessment and behavioral tests;
- No metal implantation in the head, no history of neurological problems or head injury.
You may not qualify if…
- Suffering from severe cognitive dysfunction, such as a history of head trauma, cerebrovascular disease, epilepsy, etc., use of cognitive-promoting medications in the last 6 months;
- serious physical or neurological illness, a diagnosis of any other psychiatric disorder under DSM-5 criteria (except for nicotine use disorder); Other psychoactive substance abuse or dependence in the last 5 years (except nicotine).
- any contraindications to transcranial electrical stimulation.
Where it is running
- Shanghai Mental Health Center — Shanghai, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.